Ping An Good Doctor has entered into a profound and comprehensive collaboration with Pfizer China, aiming to jointly construct a dual-pronged system. This system encompasses a 'closed-loop pharmaceutical-insurance business model' and an 'integrated disease management framework involving pharmaceuticals, patients, and healthcare providers'. Within the closed-loop pharmaceutical-insurance business model, both entities will concentrate on pivotal diseases, pioneer innovative insurance products tailored to specific conditions, facilitate the early integration of select Pfizer's innovative drugs onto the Ping An Good Doctor platform, and investigate their potential incorporation into corporate health management programs and benefit packages. As for the integrated disease management framework for pharmaceuticals, patients, and healthcare providers, a holistic, full-cycle service system will be established by both parties. This system will encompass disease screening, patient education, standardized diagnostic and treatment protocols, precise medication administration, and sustained long-term follow-up. Furthermore, both sides are committed to continuously exploring new avenues for cooperation in areas such as oncology, rare diseases, vaccines, and metabolic health.